Key facts
- It has raised $5.0M; the latest was Seed Round ($3.0M) in Jul 2025.
- Notable investors include MassChallenge, Right Side Capital Management, Phoenix Investment Club (San Francisco), Mayo Clinic Platform, Unlock Capital (New York) — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Medome
- ·The full record, as it builds
Funding rounds
No funding rounds for Medome are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Medome
Developer of an artificial intelligence primary care provider designed to improve physician productivity, reduce errors, and increase patient engagement. The company's platform offers a conversational and generative AI-powered electronic health record (EHR) digital human voice-based interface, patient data collection, and symptom and risk assessment tool, enabling healthcare providers to identify at-risk individuals, improve early disease detection, and reduce disabilities.
- Sector
- Healthcare
- HQ
- Boca Raton, FL, United States
- Employees
- 46
- Website
- medome.ai/
- Ownership
- Privately Held (backing)
Medome doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medome shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medome in its N-PORT filings yet. We sweep new filings monthly.